Factors influencing pregnant women's decision to accept or decline prenatal screening and diagnosis - a qualitative study
- PMID: 39485622
- PMCID: PMC11645329
- DOI: 10.1007/s12687-024-00746-3
Factors influencing pregnant women's decision to accept or decline prenatal screening and diagnosis - a qualitative study
Abstract
Background and objective: Prenatal diagnosis for chromosomal anomalies is frequently used worldwide. It is important that pregnant women receive adequate counselling to make informed decisions regarding prenatal diagnosis. The aim of this study was to explore what factors influence pregnant women's decision-making process when accepting or declining prenatal screening and diagnosis. Methods: A qualitative study using inductive qualitative content analysis. Individual, semi-structured phone interviews were carried out during a five-month period in 2016-2017 with 24 pregnant women in the first trimester, living in a medium-sized Swedish city.
Findings: Two main themes emerged: (1)"Individual factors - The women's experiences, perceptions and values" with three categories "Attitude towards anomalies", "Worry and need for reassurance", "Self-perceived risk" and (2)"External factors - The women's perception of the test and others' views" with two categories "Test characteristics" and "Influence from others". Conclusions: Pregnant women's decision-making process regarding prenatal tests is multidimensional, affected by both individual factors such as experiences, perceptions and values, and external factors such as test characteristics and influence from others. Information about both test characteristics and the conditions tested is of help pregnant women in the decision-making process since it provides a better understanding of how having a child with the condition in question can affect them and their family. It is important that healthcare professionals giving information about and offering prenatal tests for chromosomal anomalies are aware of how their attitudes can influence women's decisions.
Keywords: Chromosome aberrations; Decision making; Genetic counseling; Information; Informed choice; Prenatal diagnosis.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and compliance with ethics guidelines: The study was approved by the Regional Ethical Review Board at the Medical Faculty of Uppsala University (Dnr 2015/227, 2015/227/1, 2015/227/2, 2015/227/3). All procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2000. Consent to participate: Verbal informed consent was obtained from all participants prior to the interview. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.BMC Pregnancy Childbirth. 2016 May 26;16(1):121. doi: 10.1186/s12884-016-0910-3. BMC Pregnancy Childbirth. 2016. PMID: 27229318 Free PMC article.
-
Pregnant women's attitudes and decision-making regarding prenatal Down syndrome screening and diagnosis: scale development and validation.BMC Pregnancy Childbirth. 2020 Jul 14;20(1):407. doi: 10.1186/s12884-020-03093-6. BMC Pregnancy Childbirth. 2020. PMID: 32664895 Free PMC article.
-
'I want a choice, but I don't want to decide'--a qualitative study of pregnant women's experiences regarding early ultrasound risk assessment for chromosomal anomalies.Midwifery. 2012 Feb;28(1):14-23. doi: 10.1016/j.midw.2010.10.015. Epub 2010 Dec 3. Midwifery. 2012. PMID: 21130549
-
Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences.BMC Pregnancy Childbirth. 2019 Jan 14;19(1):27. doi: 10.1186/s12884-018-2168-4. BMC Pregnancy Childbirth. 2019. PMID: 30642270 Free PMC article.
-
Legislating to preserve women's autonomy during pregnancy.Med Law. 1995;14(5-6):397-412. Med Law. 1995. PMID: 8868499 Review.
Cited by
-
The influence of mobile health intervention on the rate of prenatal diagnosis and pregnancy outcomes among pregnant women with high-risk prenatal screening results: protocol for a randomized controlled trial.Front Psychiatry. 2025 Jun 4;16:1582368. doi: 10.3389/fpsyt.2025.1582368. eCollection 2025. Front Psychiatry. 2025. PMID: 40534908 Free PMC article.
References
-
- Bakker M, Birnie E, Pajkrt E, Bilardo CM, Snijders RJM (2012) Low uptake of the combined test in the Netherlands–which factors contribute? Prenat. Diagn 32(13):1305–1312 - PubMed
-
- Bakst S, Romano-Zelekha O, Ostrovsky J, Shohat T (2019) Determinants associated with making prenatal screening decisions in a national study. J Obstet Gynaecol 39(1):41–48 - PubMed
-
- Bryant L, Hewison JD, Green JM (2005) Attitudes towards prenatal diagnosis and termination in women who have a sibling with Down’s syndrome. J Reprod Infant Psychol 23(2):181–198
-
- Crombag NM, Bensing JM, Iedema-Kuiper R, Schielen PC, Visser GH (2013) Determinants affecting pregnant women’s utilization of prenatal screening for Down syndrome: a review of the literature. J Matern Fetal Neonatal Med 26(17):1676–1681 - PubMed
LinkOut - more resources
Full Text Sources